Different treatment eras for relapsed and refractory primary mediastinal B-cell lymphoma patients: accessibility to CAR T cells is associated with a better prognosis in a pooled analysis of the REPRIME-FIL and the CART-SIE studies

Anna Guidetti, Irene Dogliotti, Annalisa Chiappella, Emilio Iannitto, Andrea Evangelista, Anna Dodero, Alice Di Rocco, Monica Balzarotti, Beatrice Casadei, Federica Cavallo, Alessandro Re, Mirko Farina, Stefania Bramanti, Patrizia Chiusolo, Massimo Martino, Maurizio Musso, Manuela Zanni, Giovanni Grillo, Emanuele Ravano, Mauro Krampera, Stefan Hohaus, Maurizio Martelli, Giulia Zacchi, Carlo Visco, Pier Luigi Zinzani, Ugo Consoli, Paolo Corradini

Open source

DOI
10.3324/haematol.2026.300977
Published
2026-09-24
Container
Haematologica
Publisher
Ferrata Storti Foundation (Haematologica)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3324/haematol.2026.300977,
  title = {Different treatment eras for relapsed and refractory primary mediastinal B-cell lymphoma patients: accessibility to CAR T cells is associated with a better prognosis in a pooled analysis of the REPRIME-FIL and the CART-SIE studies},
  author = {Anna Guidetti and Irene Dogliotti and Annalisa Chiappella and Emilio Iannitto and Andrea Evangelista and Anna Dodero and Alice Di Rocco and Monica Balzarotti and Beatrice Casadei and Federica Cavallo and Alessandro Re and Mirko Farina and Stefania Bramanti and Patrizia Chiusolo and Massimo Martino and Maurizio Musso and Manuela Zanni and Giovanni Grillo and Emanuele Ravano and Mauro Krampera and Stefan Hohaus and Maurizio Martelli and Giulia Zacchi and Carlo Visco and Pier Luigi Zinzani and Ugo Consoli and Paolo Corradini},
  year = {2026},
  journal = {Haematologica},
  doi = {10.3324/haematol.2026.300977},
  url = {https://doi.org/10.3324/haematol.2026.300977}
}

RIS

TY  - JOUR
TI  - Different treatment eras for relapsed and refractory primary mediastinal B-cell lymphoma patients: accessibility to CAR T cells is associated with a better prognosis in a pooled analysis of the REPRIME-FIL and the CART-SIE studies
AU  - Anna Guidetti
AU  - Irene Dogliotti
AU  - Annalisa Chiappella
AU  - Emilio Iannitto
AU  - Andrea Evangelista
AU  - Anna Dodero
AU  - Alice Di Rocco
AU  - Monica Balzarotti
AU  - Beatrice Casadei
AU  - Federica Cavallo
AU  - Alessandro Re
AU  - Mirko Farina
AU  - Stefania Bramanti
AU  - Patrizia Chiusolo
AU  - Massimo Martino
AU  - Maurizio Musso
AU  - Manuela Zanni
AU  - Giovanni Grillo
AU  - Emanuele Ravano
AU  - Mauro Krampera
AU  - Stefan Hohaus
AU  - Maurizio Martelli
AU  - Giulia Zacchi
AU  - Carlo Visco
AU  - Pier Luigi Zinzani
AU  - Ugo Consoli
AU  - Paolo Corradini
PY  - 2026
JO  - Haematologica
DO  - 10.3324/haematol.2026.300977
UR  - https://doi.org/10.3324/haematol.2026.300977
ER  - 

APA

Guidetti, A., Dogliotti, I., Chiappella, A., Iannitto, E., Evangelista, A., Dodero, A., Rocco, A. D., Balzarotti, M., Casadei, B., Cavallo, F., Re, A., Farina, M., Bramanti, S., Chiusolo, P., Martino, M., Musso, M., Zanni, M., Grillo, G., Ravano, E., Krampera, M., Hohaus, S., Martelli, M., Zacchi, G., Visco, C., Zinzani, P. L., Consoli, U., & Corradini, P. (2026). Different treatment eras for relapsed and refractory primary mediastinal B-cell lymphoma patients: accessibility to CAR T cells is associated with a better prognosis in a pooled analysis of the REPRIME-FIL and the CART-SIE studies. Haematologica. https://doi.org/10.3324/haematol.2026.300977

Source records